Diagnostics News and Research

RSS

MGC Diagnostics fourth quarter revenue increases 11% to $9.1 million

MGC Diagnostics Corporation, a global medical technology company, today reported financial results for the fourth quarter and year ended October 31, 2013.

19 Dec 2013

TGen, Nemucore, and Barrow collaboration aims for new drugs to treat glioblastoma

The Ben & Catherine Ivy Foundation today announced a $3 million grant to the Translational Genomics Research Institute (TGen), Nemucore Medical Innovations Inc., and Barrow Neurological Institute at St. Joseph's Hospital and Medical Center to help fund significant brain tumor research in Arizona.

18 Dec 2013

Study identifies atrial fibrillation as a growing and serious global health problem

Atrial fibrillation, long considered the most common condition leading to an irregular heartbeat, is a growing and serious global health problem, according to the first study ever to estimate the condition's worldwide prevalence, death rates and societal costs.

18 Dec 2013

UCLA researchers find no evidence of association between iron levels and atherosclerosis risk

A UCLA research team has found no evidence of an association between iron levels in the body and the risk of atherosclerosis, the hardening and narrowing of the arteries that leads to cardiovascular disease, the No. 1 killer in the U.S.

18 Dec 2013

New projects advance treatments for radiation syndrome, cardiac arrest-induced brain injury and rare blood disorder

The National Institutes of Health today has launched three pre-clinical projects to advance potential new treatments for acute radiation syndrome, brain injury following cardiac arrest and a rare blood disorder called beta thalassemia.

17 Dec 2013

Navidea seeks FDA approval for marketing Lymphoseek Injection for SLN detection

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, announced today that it has submitted a Supplemental New Drug Application with the U.S. Food and Drug Administration seeking approval for the marketing and sale of Lymphoseek (technetium 99m tilmanocept) Injection for sentinel lymph node detection in patients with head and neck cancer, an indication for which Lymphoseek was also granted Fast Track designation earlier this month.

17 Dec 2013

Researchers use ATX-Red AR-2 as new imaging agent to illuminate tumors

Researchers from Echelon Biosciences, Inc. and collaborators from the University of Utah report the use of ATX-Red AR-2 as a new imaging agent that effectively illuminates tumors.

17 Dec 2013

HIV self-test screening strategy: an interview with Dr. Nitika Pant Pai, McGill University

Conventional health facility based HIV testing is plagued with poor rates of testing and has been around for the past 15+ years. Further, about 40-60% of individuals tested in facilities are lost to follow up.

17 Dec 2013

Eurofins Medigenomix, Orion Diagnostica Oy sign co-exclusive technology license agreement

Eurofins Medigenomix, a part of the Eurofins Genomics Business line of Eurofins Scientific and Orion Diagnostica Oy, an in vitro diagnostics company specialising in the development, production and sales of diagnostic test systems, announced that they have signed a co-exclusive technology license agreement. Orion Diagnostic Oy owns the global rights for the SIBA- isothermal nucleic acid detection technology in all fields.

17 Dec 2013

New regulation for cancer-causing protein may help develop targeted therapies

Researchers with the Cincinnati Cancer Center (CCC) and the University of Cincinnati (UC) Cancer Institute have discovered a new regulation for the cancer-causing protein KRas which may help with the development of targeted therapies for patients with a KRas mutation.

17 Dec 2013

Two on-the-rise esophagus conditions can be the result of food allergy, say doctors

Researchers at the UNC School of Medicine found that two on-the-rise esophagus conditions are so similar that even a biopsy is not enough to distinguish one disease from the other.

17 Dec 2013

Researchers construct "golden trap" capable of capturing molecules

The method's high sensitivity lies in the customized environment for the substance of interest. Dresden's Adrian Keller and his colleagues have constructed a type of "golden trap" capable of capturing the molecules and thereby enabling their detection.

16 Dec 2013

PAM50 FDA-cleared breast cancer test to be launched at ARUP Laboratories

The PAM50 breast cancer signature developed at the University of Utah and Huntsman Cancer Institute received FDA approval and will launch at ARUP Laboratories in Salt Lake City. The test utilizes gene expression data from 50 genes weighted together with clinical variables to generate a risk category and numerical score to assess a patient's risk of distant recurrence at ten years in postmenopausal women with node-negative (Stage I or II) or node-positive (Stage II), Hormone Receptor-Positive (HR+) breast cancer.

16 Dec 2013

Study: Blue light proves to have powerful bacteria-killing ability

Blue light has proven to have powerful bacteria-killing ability in the laboratory. The potent antibacterial effects of irradiation using light in the blue spectra have now also been demonstrated in human and animal tissues. A series of groundbreaking articles that provide compelling evidence of this effect are published in Photomedicine and Laser Surgery, a peer-reviewed journal published by Mary Ann Liebert, Inc., publishers.

16 Dec 2013

New Opterra multipoint scanning confocal microscope from Bruker

Today at the 2013 American Society for Cell Biology Annual Meeting, Bruker introduced the Opterra Multipoint Scanning Confocal Microscope, which sets a new standard for integration of confocal imaging with photoactivation.

16 Dec 2013

Bay Area Lyme Foundation announces Emerging Leader Award for promising scientist in Lyme research

The Bay Area Lyme Foundation today announced the first annual Bay Area Lyme Foundation 'Emerging Leader Award' and a $100,000 grant which will be given to a promising scientist who embodies the future of leadership in Lyme disease research.

16 Dec 2013

Cornell engineers create smartCARD that uses smartphone's camera to read cholesterol level

With a new smartphone device, you can now take an accurate iPhone camera selfie that could save your life - it reads your cholesterol level in about a minute.

16 Dec 2013

Study shows effectiveness of PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay

NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced new results from a combined analysis of the Austrian Breast & Colorectal Cancer Study Group 8 (ABCSG-8) and Trans-Arimidex, Tamoxifen, Alone or in Combination (TransATAC) studies. These results, which evaluated samples from 2,137 patients, suggest that the PAM50-based Prosignaz Breast Cancer Prognostic Gene Signature Assay may help identify women with late distant recurrence after five years of endocrine treatment.

13 Dec 2013

New test may help decrease risk of suicidality in patients treated with antidepressants

The new test, based on research carried out at the Max Planck Institute of Psychiatry, should help doctors to decrease the risk of suicidality in patients treated with antidepressants who show certain gene markers. Sundance is completing a new round of funding to extend the initial validation results reported by the Institute. The company plans to launch the test immediately as a laboratory developed test. In addition, clinical studies in support of a U.S. Food and Drug Administration submission for market clearance, CE marking and reimbursement will be initiated. Sundance expects to submit its application to the agencies within 18 months.

13 Dec 2013

Experts develop innovative technologies to improve healthcare and border security

With a solemn ceremony organized on December 11, 2013 NCBJ concluded the 85.5 million PLN worth "AiD" R&D project co-financed by European Union. Project outcomes include 3 demonstrators of innovative medical devices (Coline 6, IntraLine, and InLine PN50) and 2 demonstrators of cargo scanners developed to improve security at European border crossing checkpoints (SWAN and CANIS).

13 Dec 2013

Diagnostics News and Research

MGC Diagnostics fourth quarter revenue increases 11% to $9.1 million

TGen, Nemucore, and Barrow collaboration aims for new drugs to treat glioblastoma

Study identifies atrial fibrillation as a growing and serious global health problem

UCLA researchers find no evidence of association between iron levels and atherosclerosis risk

New projects advance treatments for radiation syndrome, cardiac arrest-induced brain injury and rare blood disorder

Navidea seeks FDA approval for marketing Lymphoseek Injection for SLN detection

Researchers use ATX-Red AR-2 as new imaging agent to illuminate tumors

HIV self-test screening strategy: an interview with Dr. Nitika Pant Pai, McGill University

Eurofins Medigenomix, Orion Diagnostica Oy sign co-exclusive technology license agreement

New regulation for cancer-causing protein may help develop targeted therapies

Two on-the-rise esophagus conditions can be the result of food allergy, say doctors

Researchers construct "golden trap" capable of capturing molecules

PAM50 FDA-cleared breast cancer test to be launched at ARUP Laboratories

Study: Blue light proves to have powerful bacteria-killing ability

New Opterra multipoint scanning confocal microscope from Bruker

Bay Area Lyme Foundation announces Emerging Leader Award for promising scientist in Lyme research

Cornell engineers create smartCARD that uses smartphone's camera to read cholesterol level

Study shows effectiveness of PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay

New test may help decrease risk of suicidality in patients treated with antidepressants

Experts develop innovative technologies to improve healthcare and border security

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News